Citations

Clear

6274 citation(s) found for "To, Andrew".

Type 2 Myocardial Infarction: Evolving Approaches to Diagnosis and Risk-Stratification
Chapman, Andrew R. , Sandoval, Yader

Mayo Clinic

Clinical Chemistry | July 31, 2020 | Volume: 67 | Issue: 1 | Pages: 61-69

10.1093/clinchem/hvaa189 | PMID 33418588 Get It

Abstract Background Type 2 myocardial infarction (T2MI) is frequently encountered in clinical practice and associated with adverse outcomes. Content T2MI occurs most frequently due to noncoronary etiologies that alter myocardial oxygen supply and/or demand. The diagnosis of T2MI is often confused with acute nonischemic myocardial injury, in part because of difficulties in delineating the nature of symptoms and misunderstandings about disease categorization. The use of objective features of myocardial ischemia using electrocardiographic (ECG) or imaging abnormalities may facilitate more precise T2MI diagnosis. High-sensitivity cardiac troponin (hs-cTn) assays allow rapid MI diagnosis and risk stratification, yet neither maximum nor delta values facilitate differentiation of T2MI from T1MI. Several investigational biomarkers have been evaluated for T2MI, but none have robust data. There is interest in evaluating risk profiles among patients with T2MI. Clinically, the magnitude of maximum and delta cTn values as well as the presence and magnitude of ischemia on ECG or imaging is used to indicate disease severity. Scoring systems such as GRACE, TIMI, and TARRACO have been evaluated, but all have limited to modest performance, with substantial variation in time intervals used for risk-assessment and endpoints used. Summary The diagnosis of T2MI requires biomarker evidence of acute myocardial injury and clear clinical evidence of acute myocardial ischemia without atherothrombosis. T2MIs are most often caused by noncoronary etiologies that alter myocardial oxygen supply and/or demand. They are increasingly encountered in clinical practice and associated with poor short- and long-term outcomes. Clinicians require novel biomarker or imaging approaches to facilitate diagnosis and risk-stratification.
GTPase Regulator Associated with Focal Adhesion Kinase 1 (GRAF1) Immunoglobulin‐Associated Ataxia and Neuropathy
Pittock, Sean J. , Alfugham, Nora, Hinson, Shannon R., Kunchok, Amy , Lennon, Vanda A. , Komorowski, Lars , Probst, Christian , O'Connor, Kevin, Hinson, Shannon, Pittock, S J , Pittock, Sean J , O’Connor, Kevin C. , McKeon, Andrew

Mayo Clinic

Movement Disorders Clinical Practice | July 30, 2020 | Volume: 7 | Issue: 8 | Pages: 904-909

10.1002/mdc3.13036 | PMID 33163561 Get It

AbstractBackgroundTo date, 10 patients with GTPase Regulator Associated with Focal Adhesion Kinase 1/Rho GTPase Activating Protein 26‐Immunoglobulin (GRAF1/ARHGAP26‐IgG) associated neurological disorders have been described, most with ataxia.ObjectiveTo report the clinical, oncological, and radiological associations of GRAF1 autoantibodies.MethodsWe identified 17 patients whose serum and/or cerebrospinal fluid IgG was confirmed to target GRAF1/ARHGAP26‐IgG by both tissue‐based immunofluorescence and transfected cell‐based assay. Clinical information was available on 14 patients.ResultsThe median age at neurological symptom onset was 51 years, and 8 (47%) were men. The predominant clinical features were subacute progressive cerebellar ataxia (13) or peripheral neuropathy (2). Magnetic resonance imaging brain (7 available) showed cerebellar atrophy (4, 1 also cerebrum and brainstem atrophy). Of 7 cerebrospinal fluids available for testing, 5 showed pleocytosis with oligoclonal bands in 3. Squamous cell carcinoma was observed in 3 patients (head and neck [2], lung [1]).ConclusionGTPase Regulator Associated with Focal Adhesion Kinase 1 autoimmunity manifests commonly with subacute ataxia and cerebellar degeneration with a potential association with squamous cell carcinoma. Peripheral neuropathy may also be encountered. Cases in this series responded poorly to immunotherapy.
Visual and Anatomic Outcomes following Cataract Surgery in Patients with Pre-operative Macular Edema Due to Retinal Vein Occlusions Managed with Intravitreal anti-VEGF
Starr, Matthew R. , Mahr, Michael A. , Iezzi, Raymond , Bakri, Sophie J. , Barkmeier, Andrew J. , Starr, Matthew R

Mayo Clinic

Seminars in Ophthalmology | July 28, 2020 | Volume: 35 | Issue: 4 | Pages: 205-209

10.1080/08820538.2020.1772319 | PMID 32721186 Get It

SIRT7‐mediated modulation of glutaminase 1 regulates TGF‐β‐induced pulmonary fibrosis
Choudhury, Malay , Yin, Xueqian , Schaefbauer, Kyle, Kang, Jeong Han , Leof, Edward B. , Schaefbauer, Kyle J., Kottom, Theodore J. , Roy, Bhaskar, Limper, Andrew H.

Mayo Clinic

The FASEB Journal | July 27, 2020 | Volume: 34 | Issue: 7 | Pages: 8920-8940

10.1096/fj.202000564r | PMID 32519817 Get It

Abstract In the current work we show that the profibrotic actions of TGF‐β are mediated, at least in part, through a metabolic maladaptation in glutamine metabolism and how the inhibition of glutaminase 1 (GLS1) reverses pulmonary fibrosis. GLS1 was found to be highly expressed in fibrotic vs normal lung fibroblasts and the expression of profibrotic targets, cell migration, and soft agar colony formation stimulated by TGF‐β required GLS1 activity. Moreover, knockdown of SMAD2 or SMAD3 as well as inhibition of PI3K, mTORC2, and PDGFR abrogated the induction of GLS1 by TGF‐β. We further demonstrated that the NAD‐dependent protein deacetylase, SIRT7, and the FOXO4 transcription factor acted as endogenous brakes for GLS1 expression, which are inhibited by TGF‐β. Lastly, administration of the GLS1 inhibitor CB‐839 attenuated bleomycin‐induced pulmonary fibrosis. Our study points to an exciting and unexplored connection between epigenetic and transcriptional processes that regulate glutamine metabolism and fibrotic development in a TGF‐β‐dependent manner.
Longitudinal health‐related quality of life in first‐line treated patients with chronic lymphocytic leukemia: Results from the Connect® CLL Registry
Sharman, Jeff P. , Cocks, Kim , Nabhan, Chadi , Lamanna, Nicole , Grinblatt, David L. , Flowers, Christopher R. , Kiselev, Pavel , Swern, Arlene S., Sullivan, Kristen , Gharibo, Mecide, Flick, E. Dawn, Trigg, Andrew , Mato, Anthony R. , Kay, Neil E. , Davids, Matthew S.

Mayo Clinic

eJHaem | July 26, 2020 | Volume: 1 | Issue: 1 | Pages: 188-198

10.1002/jha2.67 | PMID 35847738 Get It

AbstractHealth‐related quality of life (HRQoL) in patients with chronic lymphocytic leukemia (CLL) is important in guiding treatment decisions. However, the impact of CLL treatment initiation on HRQoL is unclear. We assessed HRQoL using the FACT‐Leu and EQ‐5D‐3L questionnaires in the Connect® CLL Registry, a large, US‐based, multicenter, prospective observational study of CLL patients enrolled between 2010 and 2014, prior to the introduction of novel therapies. Among 889 patients initiating first‐line therapy with chemoimmunotherapy or rituximab monotherapy, questionnaire completion rates were 95.7% and 95.8% at enrollment, and 70.8% and 69.4% at 12 months, for FACT‐Leu Total and EQ‐5D‐3L, respectively. For 849 patients completing all five FACT‐Leu components, average total scores were 135.7 at enrollment and 141.6 at 12 months. Among 526 patients with FACT‐Leu Total scores at enrollment and 12 months, clinically meaningful (≥11‐point) improvements or reductions were observed in 179 (34.0%) and 88 (16.7%) patients, respectively. Mean EQ‐5D‐3L index scores were 0.87 at enrollment and 12 months. Among 513 patients completing EQ‐5D‐3L at enrollment and 12 months, clinically meaningful (≥0.06‐point) improvements or reductions were observed in 125 (24.4%) and 116 (22.6%) patients, respectively. In the Connect® CLL Registry, HRQoL remained stable or slightly improved after 12 months of follow‐up.
Evaluation of patient-level retrieval from electronic health record data for a cohort discovery task
Chamberlin, Steven , Cohen, Aaron , Wang, Yanshan , Hersh, William , Liu, Sijia , Hersh, William , Wang, Yanshan , Bedrick, Steven , Wen, Andrew , Liu, Hongfang

Mayo Clinic

JAMIA Open | July 26, 2020 | Volume: 3 | Issue: 3 | Pages: 395-404

10.1093/jamiaopen/ooaa026 | PMID 33215074 Get It

Abstract Objective Growing numbers of academic medical centers offer patient cohort discovery tools to their researchers, yet the performance of systems for this use case is not well understood. The objective of this research was to assess patient-level information retrieval methods using electronic health records for different types of cohort definition retrieval. Materials and Methods We developed a test collection consisting of about 100 000 patient records and 56 test topics that characterized patient cohort requests for various clinical studies. Automated information retrieval tasks using word-based approaches were performed, varying 4 different parameters for a total of 48 permutations, with performance measured using B-Pref. We subsequently created structured Boolean queries for the 56 topics for performance comparisons. In addition, we performed a more detailed analysis of 10 topics. Results The best-performing word-based automated query parameter settings achieved a mean B-Pref of 0.167 across all 56 topics. The way a topic was structured (topic representation) had the largest impact on performance. Performance not only varied widely across topics, but there was also a large variance in sensitivity to parameter settings across the topics. Structured queries generally performed better than automated queries on measures of recall and precision but were still not able to recall all relevant patients found by the automated queries. Conclusion While word-based automated methods of cohort retrieval offer an attractive solution to the labor-intensive nature of this task currently used at many medical centers, we generally found suboptimal performance in those approaches, with better performance obtained from structured Boolean queries. Future work will focus on using the test collection to develop and evaluate new approaches to query structure, weighting algorithms, and application of semantic methods.
Characterization of the ‘White’ Appearing Clots that Cause Acute Ischemic Stroke
Mereuta, Oana Madalina , Douglas, Andrew , McCarthy, Ray, Gilvarry, Michael , Brinjikji, Waleed , Kallmes, David F. , O’Hare, Alan , Power, Sarah , Alderson, Jack , Murphy, Blathnaid , Davidson, Maria, Brederlau, Anke, Allardt, Arne , Thornton, John , Doyle, Karen , Madalina Mereuta, Oana , Fitzgerald, Seán , Rossi, Rosanna , Pandit, Abhay , Brennan, Paul, Gunnarsson, Þorsteinn , Tatlisumak, Turgut , Rentzos, Alexandros

Mayo Clinic

No container title available | July 24, 2020 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-45700/v1 Get It

Abstract Background: Most clots retrieved from patients with acute ischemic stroke are ‘red’ in color and are predominantly composed of red blood cells and fibrin. ‘White’ clots represent a less common entity and their histological composition is largely unknown.The aim of this study was to investigate the composition, imaging and procedural characteristics of ‘white’ clots retrieved by mechanical thrombectomy.Materials and Methods:Nineteen ‘white’ thrombi selected by visual inspection from 293 cases were collected as part of the multi-institutional RESTORE registry. Non-contrast computed tomography (NCCT), histological and immunohistochemical analyses were performed. Components were quantified using Orbit Image Analysis.Results:Quantification of Martius Scarlett Blue stain identified platelets/other as the major component in ‘white’ clots’ (63%) followed by fibrin (26%), red blood cells (7%) and white blood cells (4%). ‘White’ clots presented significantly more platelets/other and less red blood cells compared to the ‘red’ clots which showed a mean of 23% and 44%, respectively. The mean platelet (CD42b) content in ‘white’ clots was 43%; von Willebrand Factor (vWF) mean expression was 38%.Collagen and calcification were associated in one case. Fatty acid binding protein 4 was expressed in two cases.‘White’ clots were also significantly smaller (9.5 versus 12 mm) and less hyperdense (52 versus 61 Hounsfield Units) on NCCT compared to the other cases.Conclusions:‘White’ clots represented 6% of our cohort and are platelet and vWF-rich. Calcification, collagen and adipocytes were found occasionally. ‘White’ clots differ from other clots in composition, size and density on NCCT.
Influence of single parenthood on cardiopulmonary function in pediatric patients with sickle cell anemia
Zhang, Xu , Minniti, Caterina P. , Campbell, Andrew , Rana, Sohail , Luchtman‐Jones, Lori , Sable, Craig , Dham, Niti , Ensing, Gregory J., Arteta, Manuel , Taylor, James G. , Hsu, Lewis L. , Gordeuk, Victor R. , Kershaw, Kiarri N. , Darbari, Deepika S. , Nekhai, Sergei

Mayo Clinic

Blood Advances | July 24, 2020 | Volume: 4 | Issue: 14 | Pages: 3311-3314

10.1182/bloodadvances.2020002077 | PMID 32706890 Get It

In Reply: A Comparison of Minimally Invasive and Open Transforaminal Lumbar Interbody Fusion for Grade 1 Degenerative Lumbar Spondylolisthesis: An Analysis of the Prospective Quality Outcomes Database
Chan, Andrew K. , Bission, Erica F, Bydon, Mohamad , Mummaneni, Praveen V.

Mayo Clinic

Neurosurgery | July 24, 2020 | Volume: 87 | Issue: 5 | Pages: E609-E610

10.1093/neuros/nyaa372 | PMID 32814967 Get It